Stockholders of ChronoScale Holdings Corporation, whose shares are identified as ChronoScale Corporation Common Stock (NASDAQ:CHRN), elected all seven board nominees and approved four other proposals at the company’s 2026 annual meeting, according to preliminary voting results.
The proposals included the ratification of the company’s auditor for fiscal 2027, an advisory vote on executive compensation and the ratification of restricted stock awards for non-employee directors.
Jerome Wong, ChronoScale’s chief financial officer and corporate secretary, said the results remain subject to a final count certified by the inspector of election. The company plans to report the final results in a Form 8-K filed with the Securities and Exchange Commission within four business days after the meeting.
Board and Auditor Votes
Wong said the seven elected directors will serve until the next annual meeting of stockholders. They are Wes Cummins, Ying Cenly Chen, Richard Nottenburg, Ella Benson, Douglas Miller, William Clancy and Andrew Schaap.
Stockholders also ratified the appointment of CBIZ CPAs P.C. as ChronoScale’s independent registered public accounting firm for fiscal 2027, Wong said.
The board had recommended votes in favor of each director nominee and all four other proposals presented at the meeting.
Compensation and Stock Awards
In an advisory vote, stockholders approved the compensation of ChronoScale’s named executive officers as described in the proxy materials, according to Wong.
Stockholders also ratified certain restricted stock awards granted to the company’s non-employee directors under its 2026 Omnibus Equity Incentive Plan.
A fifth proposal authorized adjournment of the annual meeting if there were insufficient votes for, or otherwise in connection with, approval of one or more of the other proposals. Wong said stockholders approved that measure on a preliminary basis.
Meeting Proceedings
Cummins, the board chairman, said the inspector of election had advised that two-thirds of the voting power of outstanding shares entitled to vote was present, establishing a quorum. The board set Sept. 10, 2026, as the record date for determining which stockholders were entitled to notice of and to vote at the meeting.
Cummins said the company had not received advance notice of any additional stockholder business, so voting was confined to the proposals in the proxy statement. When Cummins opened the meeting to questions about the proposals or the company, Wong said there were none.
The company did not provide individual vote totals during the meeting. Cummins adjourned the meeting after Wong reported the preliminary results.
About ChronoScale Corporation Common Stock (NASDAQ:CHRN)
Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.
